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Abstract
Objective—Despite mounting evidence supporting the use of psychosocial interventions to 
promote adaptation to cancer, enrolling participants into these interventions is challenging. This is 
particularly salient for couple-based interventions, and newer, more targeted recruitment strategies 
to increase enrollment are needed. However, there have been few published empirical studies 
focused specifically on recruitment–related variables associated with enrollment into these types 
of interventions. To better understand how to encourage participation in couple-based 
psychosocial interventions for cancer, we examined facilitating and impeding factors to 
enrollment into a couple-based intervention for women with early stage breast cancer.
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Method—In this sample of 99 women diagnosed with early stage breast cancer, patient 
demographic variables and method of approaching eligible patients were examined as predictors 
of enrollment into a randomized controlled trial comparing Couple-Based Relationship 
Enhancement with treatment-as-usual.
Results—Results indicated that women were more likely to enroll if they were contacted at 
home or at a follow-up medical appointment rather than when first diagnosed at a busy 
multidisciplinary clinic; they were also more likely to enroll the closer they lived to the research 
facility.
Conclusions—In addition to decreasing participant burden, timing and setting of recruitment 
efforts may have important implications for enhancing participation rates in couple-based 
intervention studies for cancer.
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Introduction
Physical illness can have a psychological impact on the individual with the medical 
condition as well as on his or her socio-environmental context, including the patient’s 
spouse or committed partner [1]. This is characteristic of many cancers [2], but is especially 
so in the case of breast cancer, which may be thought of as a “relational” cancer given the 
impact of treatment on changes in women’s bodies, body image, and sexual functioning for 
both partners (see [3] for a review). A recent meta-analysis has demonstrated the efficacy of 
individually-delivered psychosocial interventions to help address the psychological 
consequences of breast cancer [4]. In addition, due to the effects on both partners, several 
couple-based treatments have been developed for breast cancer, indicating positive effects 
for one or both partners [5–9]. Nonetheless, accrual to clinical trials in this area can be 
challenging.
When individuals are diagnosed with cancer, the rationale for a psychosocial intervention 
may not immediately be obvious to them. These challenges are compounded when recruiting 
for couple-based psychosocial treatment studies because both members of the couple need to 
agree to participate, yet one or both partners may view the cancer as an individually-based 
medical condition rather than an impetus for couple-based psychosocial intervention. 
Several treatment outcome studies of individually-based psychosocial treatments for breast 
and other cancer indicate that one-third to two-thirds of eligible patients enroll despite their 
being asked to participate in multiple assessments and treatment sessions [10–14]. Looking 
to the literature to inform recruitment strategies for couple-based psychosocial interventions 
is less straightforward, complicated by the paucity of empirical studies that address this 
issue specifically and the fact that few published couple-based psychosocial treatment 
outcome studies for breast cancer or other medical conditions provide detailed descriptions 
of their recruitment procedures, the relative effectiveness of these approaches (e.g., 
percentage of eligible individuals approached who enrolled in the study), and a 
comprehensive list of reasons that eligible individuals declined participation. Furthermore, 
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among the studies that do provide information about their recruitment experiences, a wide 
range of enrollment rates emerge across interventions (e.g., 4% [15] vs. 94% [9]). Reasons 
for this variability are unclear, perhaps because it is uncommon for researchers to 
empirically examine specific variables that might increase or decrease the likelihood of a 
participant’s enrollment into a couple-based intervention for medical problems such as 
cancer. Indeed, several groups of authors [16–17] have noted that investigators do not 
commonly provide detailed descriptions of recruitment procedures and their usefulness in 
clinical trials, suggesting that this phenomenon is not limited to couple-based psychosocial 
interventions for breast cancer.
One notable exception is a report by Northouse and colleagues [17], who provided extensive 
details regarding their empirical investigation focused on recruitment and retention efforts in 
the context of a multi-site couple-based intervention for males with prostate cancer. The 
investigators reported an enrollment rate of 68% and noted differences in enrollment rates 
across sites (urban setting vs. non-urban) and stage of disease. Specifically, patients from an 
urban setting were less likely to enroll, as were patients with advanced cancer. Manne and 
colleagues [7] also provided useful details regarding recruitment for their couple-based 
group intervention for women with early stage breast cancer, reporting that the most 
common reason for refusal to participate was time and that younger patients were more 
likely to enroll than were older patients.
Detailed descriptions of recruitment procedures, reported utility of different recruitment 
strategies, and empirical evaluation of variables that might account for variability in 
enrollment rates for couple-based interventions for breast cancer or cancer more generally 
are important, as these might ultimately aid investigators in adapting their recruitment 
procedures to maximize the number of eligible participants enrolled in a particular 
intervention. High levels of recruitment are important not only to be able to generalize 
findings from treatment outcome research but also to provide services to the widest range of 
couples possible. Accordingly, the goal of the present study was to describe and empirically 
assess facilitating and impeding factors to enrollment into a couple-based psychosocial 
intervention for women with early stage breast cancer, with a focus on demographic 
variables and method of approaching eligible participants.
Methods
Participants
Ninety-nine women were recruited for enrollment into a couple-based intervention for early 
stage breast cancer at an academic, comprehensive cancer center-based practice [18]. Study 
participation involved random assignment to a six-session couple-based relationship 
enhancement program (Relationship Enhancement) or treatment as usual (TAU) and 
completion of four assessments consisting of self-report questionnaires and videotaped 
communication samples over the course of the study, each of which lasted approximately 
two hours. A woman was approached for participation in the study if (a) she was diagnosed 
with stage I or stage II breast cancer within the previous year and had no history of breast 
cancer or any other cancer within 5 years; (b) she and her male partner were currently 
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married or living together in a committed relationship for at least 12 months; (c) both 
partners were able to speak English; and (d) both partners were willing to participate.
The mean age of eligible women approached for participation in the study was 52.6 years 
(SD = 11.5; range = 28–82), and 20% were of a racial/ethnic minority (14% African-
American, 1% Latino, and 5% other). The catchment area for the cancer center was large, 
drawing women from around the state. On average, women lived 52.8 miles (SD = 47.8; 
range = 3 to 249) from the treatment facility and had received their diagnoses an average of 
14.7 days (SD = 16.2, range = 0 to 91 days) prior to being recruited.
Procedures
All assessments and treatment sessions were conducted at a research treatment facility 
approximately two miles away from the UNC Medical Center. All participants gave written 
informed consent, and the study was approved by the local Institutional Review Board.
A woman’s eligibility was determined by research staff who reviewed her medical records 
prior to her first appointment at the weekly multidisciplinary breast cancer clinic at the 
University of North Carolina (UNC) Hospital, an academic medical center and public 
hospital that serves the state of North Carolina. During her visit to the clinic, each woman 
receives care from a variety of health care providers, including medical, surgical, and 
radiation oncologists, surgical nurses, research staff, radiologists, geneticists, and patient 
counselors. She can spend one to six hours at the clinic waiting for appointments, being 
examined, and discussing assessment results and treatment options with health care 
providers. A woman typically receives her breast cancer diagnosis shortly before or at her 
first visit to the multidisciplinary clinic.
The initial recruitment strategy involved attempting to approach eligible women at the 
multidisciplinary breast clinic shortly after diagnosis. At the clinic, a clinical psychology 
doctoral student or an undergraduate research assistant with extensive cancer center 
recruitment experience briefly described the program to the woman and asked permission to 
contact her by phone the following week to describe the program further. If, for some 
reason, the woman was not able to be seen that day at the multidisciplinary clinic (e.g., she 
had back-to-back appointments with medical staff and there was no time for her to be seen 
by research staff, or there was a schedule change and the woman had already left the clinic 
prior to the recruiters’ arrival), a research staff member attempted to approach the eligible 
woman at a follow-up medical appointment. If this was not possible, the woman was 
contacted by telephone at home, and the study was described to her then. Although the study 
was approved by the clinical directors of the breast clinic, physicians were not asked to 
introduce the study or explicitly endorse it to participants in order to minimize physician 
burden.
Recruiters followed a script when introducing the study to prospective participants, whether 
in person or by telephone. Eligible women were informed that they had the opportunity to 
participate in a study evaluating a program designed to assist couples during the treatment of 
the woman’s breast cancer. The rationale was explained as follows: breast cancer can affect 
both the woman and her male partner and, although a breast cancer diagnosis and treatment 
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can pose difficulties, it also offers couples the opportunity to thrive rather than merely 
survive. To facilitate this process, eligible couples were being offered the opportunity to 
learn skills to promote their working as a team to address the breast cancer and to help them 
focus on the positives despite the challenges posed by the cancer and its treatment. 
Recruiters were careful to use the term “program” rather than “therapy,” “treatment,” or 
“psychological intervention” to minimize the risk of pathologizing or alienating prospective 
participants, particularly those who were not experiencing current relationship distress. If the 
woman expressed a desire to participate, the recruiter then spoke with her male partner to 
describe the study in detail. If both partners agreed to enroll, the couple was then scheduled 
for an initial study assessment session.
In the majority of cases, when a woman declined participation in the study, she 
spontaneously provided a reason (e.g., “I’m too busy right now” or “It’s not the kind of 
thing I’m interested in”), and the response was recorded by the research assistant without 
further inquiry to minimize her feeling that she had to justify her decision or that she was 
being coerced to participate. When a woman did not spontaneously share the reason for her 
decision not to enroll, the research assistant asked if she would be comfortable sharing the 
reason for her decision for our records. In all latter cases, women who declined provided a 
reason when asked.
Results
Of the 99 eligible women approached, 13.1% agreed to participate in the study, and 86.9% 
declined. For women who agreed to participate, time from introduction of the study to 
formal enrollment took an average of 37 days (SD = 26.92; range 5 to 111). As displayed in 
Table 1, the most common reason for declining was distance lived from the treatment 
facility, followed by lack of interest and lack of time.
Enrollers and decliners were similar in terms of age (enrollers: M = 52.1 years, SD = 10.3; 
decliners: M = 52.7, SD = 11.8) and race (20% of each group was a member of a racial or 
ethnic minority) but differed in terms of how far they lived from the research facility and 
how they were approached initially. With respect to distance, women who agreed to 
participate lived an average of 31.7 miles from the research facility (SD = 37.8; range 3 to 
146), compared to those who declined, who lived an average of 56 miles from the research 
facility (SD = 48.5; range 3 to 249). Among women who were initially approached at the 
multidisciplinary clinic (N = 46), 4% enrolled in the study (N = 2), and 96% declined (N = 
44); in contrast, among women who were approached outside of the multidisciplinary clinic 
(N = 53), 21% enrolled (N = 11: 9 initially contacted by phone, 2 initially approached at a 
follow-up clinic), and 79% declined (N = 42: 40 initially contacted by phone, 2 initially 
approached at a follow-up clinic). Despite the small sample size, this difference was 
significant (p = 0.02, Fisher’s exact test). Additional analyses confirmed that the difference 
in enrollment rates between the two recruitment settings was not an artifact of time since 
diagnosis, as there were no differences between enrollers and decliners in the length of time 
from when they were diagnosed with breast cancer to when they were approached for study 
participation (t(97) = −0.28, p = .78).
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Using logistic regression, we examined the collective impact of women’s age, race 
(Caucasian vs. non-Caucasian), distance from the research facility, and setting in which they 
were approached as predictors of enrollment into the study. Prior to evaluating the model, 
one woman who had enrolled was dropped for inclusion because she was an outlier with 
respect to distance. (The participant lived 146 miles from the research facility, a distance of 
more than three standard deviations from the mean of enrollees.) This resulted in a new 
sample of enrollees whose mean age was 53.5 years (SD = 9.3; range 42 to 76) and mean 
distance was 22.2 miles from the research facility (SD = 16.5; range 3 to 54). Twenty-five 
percent were of a racial/ethnic minority heritage, and 83.3% had not been approached at the 
multidisciplinary clinic.
The omnibus four-predictor model was significant (χ2 = 12.62, N = 98, df = 4, p = .01), and 
there was a significant effect for distance from the research facility (O.R. = 0.49, p = .03), 
such that for every twenty-five miles patients lived from the treatment facility, the odds of 
enrolling were approximately 50% lower. The decreasing odds of enrollment as a function 
of distance from the research facility are represented in Figure 1. There was also a 
significant effect for setting in which women were approached: the odds of a couple’s 
enrolling rather than declining to enroll were nearly five times higher (O.R. = 4.93, p = .057) 
if the woman was initially contacted by phone or approached at a follow-up clinic visit 
rather than recruited at the multidisciplinary breast clinic. Neither age (O.R. = 0.99, p = .76) 
nor race (O.R. = 1.68, p = .52) was a significant predictor of enrollment.
Discussion
Despite emerging evidence that couple-based psychosocial interventions can promote 
adaptation to one partner’s cancer, recruiting participants to these intensive studies can be a 
challenge. Evaluation of recruitment strategies is important for generalizing research 
findings and ultimately improving patient care in this area. However, with few published 
empirical reports focused specifically on recruitment–related variables associated with 
enrollment into these types of interventions, it is difficult to draw substantive conclusions 
regarding the usefulness of specific recruitment strategies to guide researchers in this field. 
The present study represents an effort to help address this gap in the extant literature.
Distance was the most commonly reported reason for declining participation, and the odds 
of enrolling decreased as the number of miles from the research facility increased, 
suggesting that distance was a proxy for burden for prospective participants. We also found 
that women approached at a busy multidisciplinary clinic shortly after initial diagnosis were 
less likely to enroll in the intervention than were those contacted by telephone at home or 
approached at a follow-up clinic. It may be that women who were approached at the 
multidisciplinary clinic were not prepared to integrate information relating to the 
psychosocial aspects of their breast cancer (e.g., relationship adjustment) because they were 
attending strongly to the medical aspects of their breast cancer (e.g., what surgery to have, 
risks and benefits of chemotherapy). In some instances, women had just recently learned of 
their breast cancer diagnosis and were somewhat overwhelmed, and many were meeting 
several physicians for the first time at that visit. As a result, they likely had trouble fully 
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absorbing additional information and considering an intervention that might have appeared 
peripheral to their care at the hospital.
There are other factors that, although not examined empirically in this investigation, also 
might have contributed to the low rate of enrollment. For example, all women were asked to 
invest a substantial amount of time to participate. Some women might have felt that four 
two-hour assessments, with the possibility of six additional 75-minute sessions if assigned to 
the Relationship Enhancement condition, was more of a commitment than they could make 
while grappling with the acute stress of their breast cancer diagnosis. Given the high time-
related demand (and, in some cases, travel-related burden) that prospective participants 
would have had to assume, limited direct physician involvement in the recruitment process 
could have been relevant as well. That is, although the study was approved by the clinical 
directors of the breast cancer center, the research protocol did not involve their introducing 
the study or explicitly endorsing it to patients as a potentially valuable component of their 
overall treatment plan. Physicians’ role in the recruitment process has been associated with 
patients’ decisions to enroll in cancer clinical trials focusing on medical intervention [19] 
and psychosocial intervention [13, 20]. Had recruitment been structured such that physicians 
encouraged participation, patients might have been more inclined to reflect on how breast 
cancer had impacted, or could impact, their individual psychological well-being and 
relationship adjustment and been more willing to consider participation despite study-related 
burden. Future research is needed to empirically assess the impact of physician involvement 
on enrollment into couple-based psychosocial interventions for cancer and patient 
perceptions of physician attitudes towards enrollment.
Our interpretations regarding study-related burden and method of approaching eligible 
participants are consistent with the experiences described by other investigators who have 
conducted couple-based psychosocial treatment outcome studies for cancer. For instance, by 
legitimizing the presence of the psychologist as a member of the treatment team and 
minimizing travel-related burden on the participants, Scott, Halford, and Ward [9] reported 
an extraordinarily high enrollment rate of 94% in their couple-based intervention for women 
with early stage breast or gynecological cancers. In that study, the psychologist was in the 
room with the physician at the time of diagnosis and conducted all four assessments and six 
intervention sessions in the participants’ homes. Similarly, in the study conducted by 
Northouse et al. [17], physicians and other medical personnel were involved in recruitment 
efforts, and all study-based assessment and treatment sessions were conducted at 
participants’ homes, significantly reducing study-related burden, and likely contributing to 
their 68% enrollment rate.
Conversely, and looking more broadly at accrual rates for psychosocial interventions for 
health, couple-based intervention studies that involve high levels of burden on the patient/
partner dyad are associated with lower rates of enrollment (e.g., 4% [15, 21]), whereas 
studies that involve a moderate level of burden have intermediate levels of enrollment, with 
rates of participation generally increasing as the burden on participants decreased and/or the 
pertinence of the intervention within a medical setting increased (e.g., 19–50% [22, 7–8], 
respectively).
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The current findings should also be considered in the context of enrollment rates in other 
types of cancer research. In general, it is frequently reported that only 5% of adult cancer 
patients participate in clinical trials [23]. However, single institution studies among breast 
cancer patients demonstrate that the rates of accrual may be greater than 30% for eligible 
patients presented with the option of trial enrollment [24]. Documented barriers to 
enrollment include: distance from trial center [23, 25], fear of randomization [26–28], 
patient perceptions of clinical trials [25, 29], and perceived burdens of trial participation [25, 
29]. Many of these issues may have been relevant in the context of the current study as well. 
Further, Stevens and Ahmedzai [30] provided evidence that feelings of “information 
overload” among breast cancer patients making treatment decisions can be a barrier to trial 
accrual, which seems to support our finding that recruitment outside of the busy 
multidisciplinary clinic was a preferred strategy.
Findings from this and other studies of accrual into cancer research suggest several 
strategies that researchers conducting couple-based psychosocial interventions for breast and 
other cancers could employ to increase enrollment. First, participant burden could be 
decreased by scheduling study-related appointments in conjunction with medical 
appointments or decreasing the number of sessions and assessments. Alternatively, study 
staff could travel to participants’ homes to complete assessments and treatment sessions; at 
the same time, this strategy does raise the question of portability and dissemination, as few 
providers could offer this level of service. In cases where treatment integrity would not be 
compromised by non-face-to-face delivery, it might be advantageous to conduct sessions by 
phone or via the internet.
A second strategy is to approach prospective participants so that the value of psychosocial 
interventions has increased salience, such as by approaching eligible patients when they are 
more likely to be grappling with the non-medical, psychological aspects of their medical 
condition (e.g., at home or at a follow-up clinic) and reinforcing the perception that the 
psychosocial intervention is an important part of patients’ overall care within a medical 
setting. Positioning study staff as integral members of patients’ treatment team and 
maximizing involvement by physicians, whom patients identify as the lead coordinator of 
their care, during the recruitment process might legitimize the psychosocial intervention as a 
valuable part of comprehensive medical treatment and mitigate disincentives due to study-
related burden. Furthermore, integration of formal psychosocial assessment of all patients in 
a multidisciplinary context and presentation of participation in a couple-based psychosocial 
treatment study as one among several strategies to address psychosocial issues arising in 
breast cancer management might also legitimize trial participation and improve the quality 
of care of all patients.
At minimum, researchers’ providing detailed descriptions of their recruitment efforts in this 
field and the relative success of the strategies they employed would be helpful to others 
conducting similar interventions. Recognition of the barriers to accrual to couple-based 
psychosocial interventions is the critical first step in efforts to overcome them, improve trial 
accrual, and facilitate rapid identification of the full benefits, costs, and optimal delivery of 
this important new tool to improve the lives of patients with breast cancer and their loved 
ones.
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Odds ratios of enrollment as a function of distance from the research facility. This graph 
displays the decreasing odds ratios of enrolling into the intervention, controlling for 
participants’ race (White vs non-White) and setting in which they were approached (at 
multidisciplinary clinic vs outside of multidisciplinary clinic)
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Table 1
Reported Reasons for Declining Enrollment (N = 86)
Reason for Declining Frequency (N) Percent (%)
Distance 35 41
Lack of interest 14 16
Time 9 11
Husband too busy 7 8
Unresponsive to follow-up 6 7
“Doing okay” 5 6
“Feeling overwhelmed” 3 4
Stated husband would not participate 2 2
Husband uninterested 1 1
“Too touchy feely” 1 1
Believed study conflicted with religious convictions 1 1
Not want any more research studies 1 1
Privacy concerns 1 1
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